Global Partnerships Silanes has demonstrated export collaboration with Hanmi Pharmaceutical to supply dyslipidemia and hypertension treatments, signaling openness to international distribution partnerships and private label opportunities in Mexico and LATAM.

Manufacturing Capacity With a sizable workforce and medium sized revenue, Silanes has manufacturing capacity that can support toll manufacturing or contract production for partners seeking a Mexico based hub for Latin America.

Cardiovascular Focus The focus on cardiovascular therapies such as hypertension and dyslipidemia points to a cardiometabolic portfolio with strong cross selling potential to hospital networks and large pharmacy chains, enabling targeted distribution opportunities and expansion of adjacent products.

CRM Advantage The use of Salesforce and analytics indicates readiness to manage partner programs, onboard distributors, and run data driven marketing campaigns, making it feasible to launch structured channel partnerships and performance tracking with new allies.

Pharmacy Access The presence of major Mexican pharmacy networks in the market landscape suggests opportunities for exclusive distribution, co branded campaigns, or private label arrangements to accelerate market penetration of cardiovascular products.